|
⚲
|
| Keyboard |
| Eastling Thomas Wilson
✚
|
|
|---|---|
| CIK # | 0001958487 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001958487] | |
| 4 | [0001958487] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| GYRE Therapeutics Inc | |
| Eastling Thomas Wilson |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 26,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2025-04-16 | Option exercise | 15,000 | $6.93 | 103,950 |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2025-04-16 | Option exercise | 15,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2024-08-14 | Grant | 26,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-10-31 | Grant | 314,652 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-10-31 | Grant | 1,866 | $0.00 |